Cerrahpaşa Medical Journal
ORIGINAL ARTICLE

115 KANSER HASTASINDA PORT KOMPLİKASYONLARININ DEĞERLENDİRİLMESİ

1.

İ.Ü. Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, İstanbul

2.

İ.Ü. Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Onkoloji Bilim Dalı; İstanbul

3.

İ.Ü.Cerrahpaşa Tıp Fakültesi, Kalp ve Damar Cerrahisi Anabilim Dalı, İstanbul

4.

SSK İstanbul Eğitim Hastanesi, Anastezi ve Reanimasyon Anabilim Dalı, İstanbul

5.

İ.Ü.Cerrahpaşa Tıp Fakültesi Genel Cerrahi Anabilim Dalı, İstanbul

Cerrahpasa Med J 2004; 35: 71-77
Read: 1432 Downloads: 646 Published: 24 November 2019

Background.- This study was conducted to evaluate complications associated with venous access devices used in long-term therapies in the cancer patients.

Methods.- One hundred and fifteen consequtive adult cancer patients in whom a subcutaneous port was inserted were evaluated retrospectively between 1996 and 2004.

Results- The total accrued sum of device-days for the 115 ports studied was 62,004 days, the average duration after placement was 539 days (range,8-2348 days), and the median duration was 382 days. Complications were identified in 11 of the 115 patients (9.5%). The average duration of ports in the complication group was 467 days (range, 8-1024 days) and median was 407 days. Complications included thrombosis (n:6; 5.1%) in which in one of the patients the catheter end was found in the right femoral vein instead of right atrium causing deep venous thrombosis, port infection (n:1; 0.8%), pneumothorax (n:1; 0.8%), mediastinal extravasation (n:1; 0.8%), port occlusion (n:1; 0.8%) and breaking of the catheter of the port (n:1; 0.8%). Port removal as a result of the complication was performed in 7 patients.

Conclusions.- The insertion technique and maintenance of sterility and safety is very important in long term intravenous access devices used in long term therapies in the cancer patients.

Files
EISSN 2687-1904